| Literature DB >> 26366428 |
Lingzhong Meng1, Jian Li2, Yi Lu3, Dajin Sun4, Yuan-Xiang Tao5, Renyu Liu6, Jin Jun Luo7.
Abstract
There is a petition for tight control of ketamine from the Chinese government to classify ketamine as a Schedule I drug, which is defined as a drug with no currently accepted medical use but a high potential for abuse. However, ketamine has unique properties that can benefit different patient populations. Scholars from the Translational Perioperative and Pain Medicine and the International Chinese Academy of Anesthesiology WeChat groups had an interactive discussion on ketamine, including its current medical applications, future research priorities, and benefits versus risks. The discussion is summarized in this manuscript with some minor edits.Entities:
Year: 2015 PMID: 26366428 PMCID: PMC4563343
Source DB: PubMed Journal: Transl Perioper Pain Med